Furthermore, FOXF1 was found to be required for oncogenic potential of tumor cells in rhabdomyosarcomas (Milewski et al, 2017; Milewski et al, 2021) and gastrointestinal stromal tumors (Ran et al, 2018). This evidence concerns the gene FOXF1 and rhabdomyosarcoma.